Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9873475rdf:typepubmed:Citationlld:pubmed
pubmed-article:9873475lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:9873475lifeskim:mentionsumls-concept:C1704689lld:lifeskim
pubmed-article:9873475lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:9873475lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:9873475lifeskim:mentionsumls-concept:C0671646lld:lifeskim
pubmed-article:9873475pubmed:issue15lld:pubmed
pubmed-article:9873475pubmed:dateCreated1999-2-2lld:pubmed
pubmed-article:9873475pubmed:abstractTextThe novel cyclopropapyrroloindole(CPI) bisalkylators were synthesized and their antitumor activity was evaluated. Among these derivatives, AT-760 (5a) in which the two 3-methoxycarbonyl-2-trifluoromethylCPI (MCTFCPI) moieties are connected with a 3,3'-(1,4-phenylene)diacryloyl group, was found to exhibit more prominent cytotoxicity and antitumor activity than U-77,779 (bizelesin) (1).lld:pubmed
pubmed-article:9873475pubmed:languageenglld:pubmed
pubmed-article:9873475pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9873475pubmed:citationSubsetIMlld:pubmed
pubmed-article:9873475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9873475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9873475pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9873475pubmed:statusMEDLINElld:pubmed
pubmed-article:9873475pubmed:monthAuglld:pubmed
pubmed-article:9873475pubmed:issn0960-894Xlld:pubmed
pubmed-article:9873475pubmed:authorpubmed-author:FukudaYYlld:pubmed
pubmed-article:9873475pubmed:authorpubmed-author:FuruseSSlld:pubmed
pubmed-article:9873475pubmed:authorpubmed-author:SetoSSlld:pubmed
pubmed-article:9873475pubmed:authorpubmed-author:TerashimaSSlld:pubmed
pubmed-article:9873475pubmed:authorpubmed-author:OomoriYYlld:pubmed
pubmed-article:9873475pubmed:authorpubmed-author:EbisuHHlld:pubmed
pubmed-article:9873475pubmed:issnTypePrintlld:pubmed
pubmed-article:9873475pubmed:day4lld:pubmed
pubmed-article:9873475pubmed:volume8lld:pubmed
pubmed-article:9873475pubmed:ownerNLMlld:pubmed
pubmed-article:9873475pubmed:authorsCompleteYlld:pubmed
pubmed-article:9873475pubmed:pagination2003-4lld:pubmed
pubmed-article:9873475pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9873475pubmed:meshHeadingpubmed-meshheading:9873475-...lld:pubmed
pubmed-article:9873475pubmed:meshHeadingpubmed-meshheading:9873475-...lld:pubmed
pubmed-article:9873475pubmed:meshHeadingpubmed-meshheading:9873475-...lld:pubmed
pubmed-article:9873475pubmed:meshHeadingpubmed-meshheading:9873475-...lld:pubmed
pubmed-article:9873475pubmed:meshHeadingpubmed-meshheading:9873475-...lld:pubmed
pubmed-article:9873475pubmed:meshHeadingpubmed-meshheading:9873475-...lld:pubmed
pubmed-article:9873475pubmed:meshHeadingpubmed-meshheading:9873475-...lld:pubmed
pubmed-article:9873475pubmed:meshHeadingpubmed-meshheading:9873475-...lld:pubmed
pubmed-article:9873475pubmed:meshHeadingpubmed-meshheading:9873475-...lld:pubmed
pubmed-article:9873475pubmed:meshHeadingpubmed-meshheading:9873475-...lld:pubmed
pubmed-article:9873475pubmed:meshHeadingpubmed-meshheading:9873475-...lld:pubmed
pubmed-article:9873475pubmed:year1998lld:pubmed
pubmed-article:9873475pubmed:articleTitleThe novel cyclopropapyrroloindole(CPI) bisalkylators bearing 3,3'-(1,4-phenylene)diacryloyl group as a linker.lld:pubmed
pubmed-article:9873475pubmed:affiliationCentral Research Laboratories, Kyorin Pharmaceutical Co. Ltd., Tochigi, Japan.lld:pubmed
pubmed-article:9873475pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:9873475lld:chembl